TITLE:
Micropenis Associated or Not with Cryptorchidism in the Endocrinology Department of Yopougon University Hospital in Ivory Coast: Epidemiological, Clinical, Paraclinical and Therapeutic Aspects
AUTHORS:
Adélaïde Hue, Kossi Kodjo, Michèle Fotso, Jacko Abodo
KEYWORDS:
Micropenis, Cryptorchidism, Hospital Environment, Ivory Coast
JOURNAL NAME:
Open Journal of Endocrine and Metabolic Diseases,
Vol.14 No.3,
March
21,
2024
ABSTRACT: Background: Congenital
malformations such as micropenis and cryptorchidism do not have immediate dramatic consequences.
However, the diagnosis is often unknown at birth, and therefore late. In Ivory
Coast, there are few studies on cryptorchidism and micropenis. We conducted
this study to identify the epidemiological, clinical, etiological and
therapeutic characteristics of the micropenis associated or not with
cryptorchidism at Yopougon University Hospital. Methods: We conducted a retrospective descriptive study in the Department
of Endocrinology-Diabetology of the Yopougon University Hospital carried out over 13 years from January 2005 to December 2018. All patients were
included regardless of the presence of a micropenis associated or not with
cryptorchidism in the clinical or paraclinical examination. Results: A total of 14 micropenis were reported associated in
6 cases with cryptorchidism. It was unilateral cryptorchidism in 4
patients or 66.66% of cases. The average age
of affected patients was 21.32 years with extremes ranging from 10 months to 48 years. The reason for consultation was micropenis in 12 out of 14 cases
or 85.75%. The associated signs apart from
cryptorchidism were obesity in 42.86% of cases, gynecomastia in 35.71%
of cases. The aetiology was dominated by idiopathic causes. Treatment with
testosterone enanthate was more effective in pre-pubertal children than in
adults. Conclusion: The diagnosis of micropenis associated or not
with cryptorchidism is late because of the frustrations, taboos and
psycho-social states that it causes. However, drug treatment is effective when
treatment is started early.